Skip to main navigation Skip to search Skip to main content

CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on b-Lactam Susceptibility

  • Natalia Kurepina
  • , Liang Chen
  • , Kaelea Composto
  • , Dalin Rifat
  • , Eric L. Nuermberger
  • , Barry N. Kreiswirth
  • Hackensack Meridian Health
  • Johns Hopkins University
  • Hackensack Meridian School of Medicine

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

We utilized a CRISPR interference (CRISPRi) assay to control the gene expressions of two predicted essential peptidoglycan biosynthesis genes, pbpB and cwIM, in Mycobacterium abscessus and to evaluate their contribution to b-lactam susceptibility. Our results showed that CRISPR inhibition of each gene led to a significant 3-log10 reduction in CFU in the presence of imipenem but not for cefoxitin. These results demonstrate that CRISPRi provides an experimental approach to study drug/ target interactions in M. abscessus.

Original languageEnglish
JournalAntimicrobial Agents and Chemotherapy
Volume66
Issue number4
DOIs
StatePublished - Apr 2022

Keywords

  • CRISPRi
  • Mycobacterium abscessus
  • b-lactam
  • peptidoglycan biosynthesis

Fingerprint

Dive into the research topics of 'CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on b-Lactam Susceptibility'. Together they form a unique fingerprint.

Cite this